Results 31 to 40 of about 1,154,039 (314)

Effect of Biological Therapy on Systemic Inflammatory Markers Among Patients with Chronic Plaque Psoriasis

, 2023
Aim:Psoriasis is a chronic systemic inflammatory disease. A generally accepted laboratory marker for monitoring the treatment response of psoriasis is not yet available.
Isil Deniz Oguz, Sevgi Kulakli
core   +1 more source

Biological therapy of cancer [PDF]

Breast Cancer Research and Treatment, 1986
Interferons and monoclonal antibodies are among the most promising biological approaches to cancer treatment which have so far been investigated. Both natural and recombinant interferon-alpha preparations have shown activity in a number of trials in hematologic malignancies, even in previously treated patients; activity in solid tumors, however, has ...
openaire   +3 more sources

Leucopenia e trombocitopenia induzidas por etanercepte: relato de dois casos e revisão da literatura Leukopenia and thrombocytopenia induced by etanercept: two case reports and literature review

Revista Brasileira de Reumatologia, 2012
O fator de necrose tumoral alfa (TNF-alfa) é uma citocina pró-inflamatória, e seu excesso pode levar a sérias consequências. Esses efeitos são conhecidos por serem antagonizados por inibidores da atividade do TNF-alfa.
Valderílio Feijó Azevedo, Marília Barreto Gameiro Silva, Débora Karine Marinello, Felipe Dunin dos Santos, Guilherme Barreto Gameiro Silva   +4 more
doaj   +1 more source

Management and efficacy of intensified insulin therapy starting in outpatients [PDF]

, 1989
Diabetic patients under multiple injection insulin therapy (i.e., intensified insulin therapy, IIT) usually start this treatment during hospitalization. We report here on the logistics, efficacy, and safety of IIT, started in outpatients.
Winkelmann, W., W. Hummerich, M. Steffen, B. Allolio, Allolio, B., G. Ollenschläger, W. Winkelmann, M. Reincke, Hummerich, W., Steffen, M., Ollenschläger, G., Reincke, Martin   +11 more
core   +1 more source

Pathogenic aspects of treatment of psoriatic patients

Vestnik Dermatologii i Venerologii, 2017
The article describes high incidence and morbidity rate of psoriasis, substantial reduction in the life quality and psychosocial disadaptation of patients, and presents certain particular features of psoriasis pathogenesis taking into consideration the ...
V. V. Chikin, L. F. Znamenskaya, A. A. Mineyeva   +2 more
doaj   +1 more source

Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents [PDF]

, 2021
Introduction: There is very limited kn3e safety of COVID-19 vaccines in patients with psoriasis who are being treated with biological agents. We present our experience in 369 patients with moderate-to-severe psoriasis undergoing therapy with anti-IL ...
Talamonti M., Galluzzo M.
core   +1 more source

Increasing the concentration of plasma molecules improves the biological activity of platelet-rich plasma for tissue regeneration

Scientific Reports
Platelet-rich plasma (PRP) has emerged as a promising therapy in a variety of medical fields. However, it is crucial to go beyond simple platelet concentration and examine the complex molecular composition both inside and outside platelets.
Mikel Sánchez, Jon Mercader Ruiz, Daniel Marijuán Pinel, Pello Sánchez, Nicolás Fiz, Jorge Guadilla, Juan Azofra, Maider Beitia, Diego Delgado   +8 more
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Association between Carotid Intima-Media Thickness and the Use of Biological or Small Molecule Therapies in Patients with Rheumatoid Arthritis

Diagnostics, 2021
Objective: The objective of this study was to assess the association of carotid intima-media thickness (CIMT), and also the presence of atheromatous plaque, with biological and targeted synthetic disease-modifying antirheumatic drugs, in an established ...
Marta Rojas-Giménez, Clementina López-Medina, Jerusalem Calvo-Gutiérrez, María Ángeles Puche-Larrubia, Ignacio Gómez-García, Pedro Seguí-Azpilcueta, María del Carmen Ábalos-Aguilera, Desirée Ruíz, Eduardo Collantes-Estévez, Alejandro Escudero-Contreras   +9 more
doaj   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source